European Cardiac Rhythm Management Devices Market
- Report Code: CA 1002
- Publish Date: Upcoming
The European cardiac rhythm management devices market, mainly driven by the increasing incidence of lifestyle diseases & cardiovascular diseases, was valued at $3.16 billion in 2012, and is projected to reach $5.98 billion by 2018.
The report analyzes the market of devices by segments such as defibrillators, pacemakers, and cardiac resynchronization therapy devices. All of these segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques. Pacemakers amount for the largest share in terms of value towards total market.
Advances in technology prove to be the major driver for the European market. But this may also hamper the future growth as e-commerce is expected to further contribute to price erosion.
The CRM devices market would also see robust growth due to factors such as rapidly aging population, higher disposable incomes, and technological innovation of products such as miniaturization, durable batteries, biocompatible materials, and government regulatory approvals. The incidence of cardiac disorders such as heart failure, cardiac arrhythmias, and cardiac arrests are increasing at a rapid rate.
The report also provides an extensive competitive landscaping of companies operating in this market. Medtronic is the market leader, and the other players in the market include St Jude Medical, Abbott Laboratories, Boston Scientific, Biotronik SE & Co. KG, Sorin. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- Adoption rate analysis of the products (segment-wise and country-wise)
Epidemiology Data:
- Country-specific prevalence of CVD
- Country-specific patient pool of CVD
- Disease progression (pattern analysis)
Procedure Volume Data:
- Number of CV procedures performed in each country
- End-users
Surgeons/Physicians Perception Matrix:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of devices by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix:
- A comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products-Impact analysis:
- MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Cardiac Rhythm Management Devices-Europe, By Segments
4.1 Split By Geography
4.1 Cardiac Rhythm Management Devices-Spain by Markets
4.1 Cardiac Rhythm Management Devices-United Kingdom by Markets
4.1 Cardiac Rhythm Management Devices-France by Markets
4.1 Cardiac Rhythm Management Devices-Germany by Markets
4.1 Cardiac Rhythm Management Devices-Italy by Markets
4.1 Cardiac Rhythm Management Devices-Rest of Europe by Markets
4.2 Defibrillators-Europe
4.2.1 Defibrillators-Europe, By Geographies
4.2.1.1 Defibrillators-Spain
4.2.1.2 Defibrillators-United Kingdom
4.2.1.3 Defibrillators-France
4.2.1.4 Defibrillators-Germany
4.2.1.5 Defibrillators-Italy
4.2.1.6 Defibrillators-Rest of Europe
4.2.2 Defibrillators-Europe, By Segments
4.2.2.1 Automated External Defibrillators (AED)-Europe
5 Cardiac Rhythm Management Devices-Europe, By Geographies
5.1 Cardiac Rhythm Management Devices-Spain
5.1.1 Cardiac Rhythm Management Devices-Spain, By Segments
5.1.1.1 Defibrillators-Spain
5.2 Cardiac Rhythm Management Devices-United Kingdom
5.2.1 Cardiac Rhythm Management Devices-United Kingdom, By Segments
5.2.1.1 Defibrillators-United Kingdom
5.3 Cardiac Rhythm Management Devices-France
5.3.1 Cardiac Rhythm Management Devices-France, By Segments
5.3.1.1 Defibrillators-France
5.4 Cardiac Rhythm Management Devices-Germany
5.4.1 Cardiac Rhythm Management Devices-Germany, By Segments
5.4.1.1 Defibrillators-Germany
5.5 Cardiac Rhythm Management Devices-Italy
5.5.1 Cardiac Rhythm Management Devices-Italy, By Segments
5.5.1.1 Defibrillators-Italy
5.6 Cardiac Rhythm Management Devices-Rest of Europe
5.6.1 Cardiac Rhythm Management Devices-Rest of Europe, By Segments
5.6.1.1 Defibrillators-Rest of Europe
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
